Fortrea Holdings Inc (K67)

Overview

Fortrea Holdings Inc. is a distinguished contract research organization that has carved a niche for itself in the provision of comprehensive development services for biopharmaceutical products and medical devices on a global scale. Established in 2023 and based in Durham, North Carolina, Fortrea Holdings Inc. distinguishes itself through its specialized operation in two core segments: Clinical Services and Enabling Services. This structured approach allows the company to cater to a wide array of needs within the biopharmaceutical and medical device development space, offering its services to pharmaceutical, biotechnology, and medical device organizations. Through its inception, Fortrea Holdings Inc. has been dedicated to advancing the field of clinical development by leveraging its expertise and innovative technologies to simplify and optimize processes for its clients worldwide.

Products and Services

• Clinical Services:

Fortrea's Clinical Services segment offers comprehensive support across the clinical pharmacology and clinical development spectrum. This includes a full range of services from early phase clinical development strategies to phase I-IV clinical trial management. By focusing on efficient and effective clinical trial execution, Fortrea ensures that its clients can advance through the development pipeline with confidence and precision.

• Enabling Services:

The Enabling Services segment is designed to streamline the clinical trial process through patient access and clinical trial technology solutions. This includes sophisticated tools for complex randomization and optimized trial drug supply processes, making clinical trials more efficient and effective. Through these services, Fortrea aims to reduce the logistical hurdles associated with clinical trials, thereby speeding up the development timeline and reducing costs for its clients.

• Delivery Models:

Understanding the varied needs of its clients, Fortrea offers multiple delivery models including full-service, functional service provider (FSP), and hybrid structures. This flexibility allows clients to choose the model that best fits their project requirements, resources, and goals, ensuring a tailored approach to clinical trial management and development services.

• Technology Enabled Trial Solutions:

Fortrea is at the forefront of integrating technology into the clinical trial process. The company provides differentiated technology-enabled solutions that facilitate every phase of clinical trials, from planning and recruitment to data collection and analysis. These innovative solutions enable higher efficiency, accuracy, and accessibility for clinical trials, propelling the industry forward and setting new standards for trial management.

• Post-Approval Services and Consulting:

Even after approval, Fortrea supports its clients with a suite of post-approval services and consulting expertise. This ensures that transitioning from development to market is as smooth and efficient as possible, offering continued support in terms of market analysis, regulatory compliance, and post-marketing studies. Furthermore, Fortrea's consulting services provide valuable insights and strategies for overcoming the unique challenges faced by biopharmaceutical and medical device companies.